Mission Viejo, CA, United States of America

Troy Rhonemus

USPTO Granted Patents = 10 (Patent Applications = 1)

CIPO Patents = 5 (Patent Applications = 2)

EPO Patents = 4 (Patent Applications = 7)

Average Co-Inventor Count = 4.1

ph-index = 3

Forward Citations = 16(Granted Patents)

Location History:

Irvine, CA (US) (2020 - 2021)
Mission Viejo, CA (US) (2018 - 2022)

Company Filing History:

The Queen's University of Belfast

patents

where one patent can have more than one assignee

Years Active: 2018-2025

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12433908 - Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy development (2025-10-07),

2. 11524022 - Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy development (2022-12-13),

3. 11214589 - Crystalline forms of nicotinoyl ribosides and derivatives thereof, and methods of preparation thereof (2022-01-04),

4. 11033568 - Nicotinamide riboside compositions for topical use in treating skin conditions (2021-06-15),

5. 10934322 - B-vitamin and amino acid conjugates of nicotinoyl ribosides and reduced nicotinoyl ribosides, derivatives thereof, and methods of preparation thereof (2021-03-02),

6. 10857172 - Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy development (2020-12-08),

7. 10688118 - Nicotinamide riboside compositions for topical use in treating skin conditions (2020-06-23),

8. 10280190 - Nicotinic acid riboside or nicotinamide riboside compositions, reduced derivatives thereof, and the use thereof to enhance skin permeation in treating skin conditions (2019-05-07),

9. 10183036 - Use of nicotinic acid riboside or nicotinamide riboside derivatives, and reduced derivatives thereof, as NAD+ increasing precursors (2019-01-22),

10. 10000520 - B-vitamin and amino acid conjugates ofnicotinoyl ribosides and reduced nicotinoyl ribosides, derivatives thereof, and methods of preparation thereof (2018-06-19),

Title: Innovator Spotlight: Troy Rhonemus - Pioneering Infant Formula Development in Mission Viejo

Introduction: Troy Rhonemus, a talented inventor based in Mission Viejo, CA, has made significant contributions to the field of infant nutrition with his groundbreaking patents. With a total of 9 patents to his name, Rhonemus is a respected figure in the scientific community.

Latest Patents: One of Rhonemus' recent patents involves the use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide in infant formula for healthy development. This innovative method delivers essential compounds alongside vitamins to support the growth of infant subjects. Another patent focuses on crystalline forms of nicotinoyl ribosides, offering new possibilities in the preparation of these compounds.

Career Highlights: Rhonemus has showcased his expertise while working at esteemed companies such as Chromadex Inc. and The Queen's University of Belfast. His experience and knowledge have been instrumental in developing groundbreaking solutions in the field of infant nutrition and wellness.

Collaborations: Throughout his career, Rhonemus has collaborated with top professionals in the industry, including coworkers like Ryan Dellinger and Marie Eugenie Migaud. These collaborations have led to innovative projects and successful patent applications that have pushed the boundaries of science and technology.

Conclusion: Troy Rhonemus' dedication to innovation and his commitment to advancing infant nutrition have established him as a prominent figure in the field. His patents and collaborations reflect his passion for creating solutions that make a real difference in the lives of people. As he continues to push the boundaries of scientific research, the future looks bright for Troy Rhonemus and his impactful contributions to the field of infant formula development.

This text is generated by artificial intelligence and may not be accurate.